KOSKI BEVERLY 4
4 · ORAGENICS INC · Filed Sep 18, 2018
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI FAMILY LP
10% Owner
Transactions
- Purchase
Common Stock
2018-09-14$0.42/sh+38,860$16,321→ 147,649 total - Purchase
Common Stock
2018-09-18$0.41/sh+22,000$9,009→ 277,839 total - Purchase
Common Stock
2018-09-14$0.41/sh+100$41→ 149,749 total - Purchase
Common Stock
2018-09-17$0.42/sh+100,000$42,000→ 255,839 total - Purchase
Common Stock
2018-09-14$0.41/sh+2,000$830→ 149,649 total - Purchase
Common Stock
2018-09-14$0.41/sh+6,090$2,526→ 155,839 total
Holdings
- 2,800(indirect: By Koski Management, Inc.)
Common Stock
- 53,086(indirect: By Trust)
Common Stock
- 91,967
Common Stock
- 1,286,483
Common Stock
- 157,254
Common Stock
Footnotes (7)
- [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Christine L. Koski.
- [F4](Shares owned directly by Robert C. Koski, a director of the Company.
- [F5]Shares owned directly by Thomas L. Koski.
- [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F7]Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,760 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (10,760 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (10,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,760 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (10,806 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.